Skip to Main Content

Author Details

Ioannis Prassas
Mount Sinai Hospital
2007
72
20
PMIDPaper TitleJournal TitlePublished Year
35930434The therapeutic relevance of the Kallikrein-Kinin axis in SARS-cov-2-induced vascular pathology.Crit Rev Clin Lab Sci2023
38077014The relationship between serum astroglial and neuronal markers and AQP4 and MOG autoantibodies.Res Sq2023
37644477Cerebrospinal fluid camk2a levels at baseline predict long-term progression in multiple sclerosis.Clin Proteomics2023
37291228B cell profiles, antibody repertoire and reactivity reveal dysregulated responses with autoimmune features in melanoma.Nat Commun2023
37327802Tachykinins and the potential causal factors for post-COVID-19 condition.Lancet Microbe2023
36959545Discovery of novel glioma serum biomarkers by proximity extension assay.Clin Proteomics2023
36788117Quantitation of neurofilament light chain protein in serum and cerebrospinal fluid from patients with multiple sclerosis using the MSD R-PLEX NfL assay.Diagnosis (Berl)2023
36655501Multiplex proteomics using proximity extension assay for the identification of protein biomarkers predictive of acute graft-vs.-host disease in allogeneic hematopoietic cell transplantation.Clin Chem Lab Med2023
36760007Prostate-Specific Antigen and Female Breast Cancer-Revisited.J Appl Lab Med2023
36941789Beyond the amyloid hypothesis: how current research implicates autoimmunity in Alzheimer's disease pathogenesis.Crit Rev Clin Lab Sci2023
35170269Ultrasensitive assay for saliva-based SARS-CoV-2 antigen detection.Clin Chem Lab Med2022
35475723Patients with severe COVID-19 do not have elevated autoantibodies against common diagnostic autoantigens.Clin Chem Lab Med2022
35512584Electronic field effect detection of SARS-CoV-2 N-protein before the onset of symptoms.Biosens Bioelectron2022
36179121Sensitive Serology Measurements in the Saliva of Individuals with COVID-19 Symptoms Using a Multiplexed Immunoassay.J Appl Lab Med2022
36287134Quantitation of cardiac troponin I in cancer patients treated with immune checkpoint inhibitors: a case-control study.Clin Chem Lab Med2022
32568598The role of kallikreins in inflammatory skin disorders and their potential as therapeutic targets.Crit Rev Clin Lab Sci2021
33730769Assay requirements for COVID-19 testing: serology vs. rapid antigen tests.Clin Chem Lab Med2021
33778875Plasma Protein Profiling by Proximity Extension Assay Technology Reveals Novel Biomarkers of Traumatic Brain Injury-A Pilot Study.J Appl Lab Med2021
34868557Comparison of two multiplexed technologies for profiling >1,000 serum proteins that may associate with tumor burden.F1000Res2021
34987469Putative Concussion Biomarkers Identified in Adolescent Male Athletes Using Targeted Plasma Proteomics.Front Neurol2021
34496166From the amyloid hypothesis to the autoimmune hypothesis of Alzheimer's disease.Diagnosis (Berl)2021
34403936CSF neurofilament light may predict progression from amnestic mild cognitive impairment to Alzheimer's disease dementia.Neurobiol Aging2021
34214386An overview of mental health during the COVID-19 pandemic.Diagnosis (Berl)2021
34144643Novel severe traumatic brain injury blood outcome biomarkers identified with proximity extension assay.Clin Chem Lab Med2021
34337287Recurrent Myocarditis Induced by Immune-Checkpoint Inhibitor Treatment Is Accompanied by Persistent Inflammatory Markers Despite Immunosuppressive Treatment.JCO Precis Oncol2021
34112739Immunotherapy using IgE or CAR T cells for cancers expressing the tumor antigen SLC3A2.J Immunother Cancer2021
33107741Proteomic Profiling of the Human Tissue and Biological Fluid Proteome.J Proteome Res2021
33241314Alzheimer Disease Pathogenesis: The Role of Autoimmunity.J Appl Lab Med2021
33347790COVID-19: from an acute to chronic disease? Potential long-term health consequences.Crit Rev Clin Lab Sci2021
32386187Antibody tests for COVID-19: drawing attention to the importance of analytical specificity.Clin Chem Lab Med2020
31904348Kallikrein-related peptidases protein expression in lymphoid tissues suggests potential implications in immune response.Clin Biochem2020
33299547Predicting response and toxicity to PD-1 inhibition using serum autoantibodies identified from immuno-mass spectrometry.F1000Res2020
33234691Kallikrein 13 serves as a priming protease during infection by the human coronavirus HKU1.Sci Signal2020
32904064Novel Outcome Biomarkers Identified With Targeted Proteomic Analyses of Plasma From Critically Ill Coronavirus Disease 2019 Patients.Crit Care Explor2020
30684468Proteome-wide onco-proteogenomic somatic variant identification in ER-positive breast cancer.Clin Biochem2019
32089828Putative autoantibodies in the cerebrospinal fluid of Alzheimer's disease patients.F1000Res2019
31415236Liquid biopsy of cerebrospinal fluid identifies neuronal pentraxin receptor (NPTXR) as a biomarker of progression of Alzheimer's disease.Clin Chem Lab Med2019
31346327Correction to: A proteome-wide immuno-mass spectrometric identification of serum autoantibodies.Clin Proteomics2019
31363009Serum PD-1 Is Elevated after Pembrolizumab Treatment but Has No Predictive Value.Mol Cancer Ther2019
31249498A proteome-wide immuno-mass spectrometric identification of serum autoantibodies.Clin Proteomics2019
31129650Screening of chemical libraries in pursuit of kallikrein-5 specific inhibitors for the treatment of inflammatory dermatoses.Clin Chem Lab Med2019
30277835Optimizing cancer immunotherapy: Is it time for personalized predictive biomarkers?Crit Rev Clin Lab Sci2018
30157030The International Society for Enzymology: a glorious history, a golden legacy.Clin Chem Lab Med2018
29928903Biochemical characterization of human tissue kallikrein 15 and examination of its potential role in cancer.Clin Biochem2018
28559305Biochemical and functional characterization of the human tissue kallikrein 9.Biochem J2017
29872704Towards personalized tumor markers.NPJ Precis Oncol2017
28157690Variant peptide detection utilizing mass spectrometry: laying the foundations for proteogenomic identification and validation.Clin Chem Lab Med2017
28376164Germline Mutations in the Kallikrein 6 Region and Predisposition for Aggressive Prostate Cancer.J Natl Cancer Inst2017
28095327Proteomic and peptidomic analysis of human sweat with emphasis on proteolysis.J Proteomics2017
29025326Onco-proteogenomics: Multi-omics level data integration for accurate phenotype prediction.Crit Rev Clin Lab Sci2017
  • 1 - 50 of 72

Recommended Authors

Tea Dodig-Crnkovi??
Columbia University
Career Start Year 2015
Number of shared co-authors 0
John F K Sauld
Emulate Inc.
Career Start Year 2013
Number of shared co-authors 0
Elisa Pin
KTH Royal Institute of Technology
Career Start Year 2007
Number of shared co-authors 0
John R Mills
Mayo Clinic
Career Start Year 2007
Number of shared co-authors 0
Athena A Schepmoes
Pacific Northwest National Laboratory
Career Start Year 2006
Number of shared co-authors 0
Wendy Sandoval
Genentech Inc.
Career Start Year 2006
Number of shared co-authors 0
Qing Zhang
Beijing Hospital of Traditional Chinese Medicine, Capital Medical University
Career Start Year 2006
Number of shared co-authors 0
Sanjeeva Srivastava
Indian Institute of Technology Bombay
Career Start Year 2004
Number of shared co-authors 1
Surendra Dasari
Mayo Clinic
Career Start Year 2004
Number of shared co-authors 0
Sharon J Pitteri
Stanford University
Career Start Year 2003
Number of shared co-authors 0
Yassene Mohammed
Center for Proteomics and Metabolomics, Leiden University Medical Center
Career Start Year 2003
Number of shared co-authors 0
Kieran Wynne
University College Dublin
Career Start Year 2002
Number of shared co-authors 0
Melinda Rezeli
Clinical Protein Science & Imaging, Biomedical Centre, Lund University
Career Start Year 2002
Number of shared co-authors 0
Tiannan Guo
Westlake University
Career Start Year 2001
Number of shared co-authors 2
Cristina C Clement
Englander Institute for Precision Medicine
Career Start Year 2001
Number of shared co-authors 0
Parag Mallick
Stanford University
Career Start Year 2000
Number of shared co-authors 1
??kos V??gv??ri
Karolinska Institutet
Career Start Year 1998
Number of shared co-authors 0
David A Sarracino
Harvard Partners Center For Genetics and Genomics
Career Start Year 1998
Number of shared co-authors 2
Thomas P Conrads
Women's Health Integrated Research Center, Inova Health System
Career Start Year 1998
Number of shared co-authors 1
Janne Lehti??
Karolinska Institutet
Career Start Year 1997
Number of shared co-authors 1
Julius O Nyalwidhe
Eastern Virginia Medical School
Career Start Year 1997
Number of shared co-authors 2
Yu-Ju Chen
Institute of Chemistry
Career Start Year 1992
Number of shared co-authors 2
Ronald C Hendrickson
Memorial Sloan Kettering Cancer Center
Career Start Year 1990
Number of shared co-authors 0
Andrea Urbani
National Research Council (CNR)
Career Start Year 1990
Number of shared co-authors 0
Emanuel F Petricoin
Center for Applied Proteomics and Molecular Medicine, George Mason University
Career Start Year 1988
Number of shared co-authors 2
Mark S Baker
Macquarie University
Career Start Year 1984
Number of shared co-authors 0
Gy??rgy Marko-Varga
Clinical Protein Science & Imaging, Biomedical Centre, Lund University
Career Start Year 1984
Number of shared co-authors 0
Daniel W Chan
Division of Clinical Chemistry, Johns Hopkins University
Career Start Year 1979
Number of shared co-authors 4
Peter Nilsson
Linkoping University
Career Start Year 1978
Number of shared co-authors 0
Edouard C Nice
Monash University
Career Start Year 1971
Number of shared co-authors 0

Collaborators

Eleftherios P Diamandis
Lunenfeld-Tanenbaum Research Institute
Co-authored papers 67
Antoninus Soosaipillai
Lunenfeld-Tanenbaum Research Institute, Mount Sinai Hospital
Co-authored papers 15
Wei Xu
Princess Margaret Cancer Centre
Co-authored papers 2
Alessandro Datti
University of Perugia
Co-authored papers 2
Tony Mazzulli
Mount Sinai Health System and University Health Network
Co-authored papers 1
Maciej Kwiatkowski
University of Basel, Academic Hospital Braunschweig
Co-authored papers 1
Yu-Jia Shiah
Ontario Institute for Cancer Research
Co-authored papers 1
Sevtap Savas
Memorial University
Co-authored papers 1
Jingxiong Xu
Lunenfeld-Tanenbaum Research Institute
Co-authored papers 1
Ants Toi
Mount Sinai Hospital, University of Toronto
Co-authored papers 1
Michael Fraser
Princess Margaret Cancer Centre, University Health Network
Co-authored papers 1
Melania Pintilie
Princess Margaret Cancer Centre, University Health Network
Co-authored papers 1
Tristan Juvet
Lions Gate Hospital
Co-authored papers 1
Ivan Pasic
Princess Margaret Cancer Centre
Co-authored papers 1
Philippe L Bedard
Princess Margaret Cancer Centre, University Health Network
Co-authored papers 1
Lillian L Siu
Princess Margaret Cancer Centre, University Ave
Co-authored papers 1
Robert G Bristow
University of Toronto
Co-authored papers 1
Karen Chadwick
University Health Network, University of Toronto
Co-authored papers 1
Cynthia Kuk
Mount Sinai Hospital, University of Toronto, University Health Network
Co-authored papers 1
Matt Friedlander
Ontario Institute for Cancer Research
Co-authored papers 1
Thomas Kislinger
Princess Margaret Cancer Centre, University Health Network, University of Toronto
Co-authored papers 1
Hilmi Ozcelik
Lunenfeld-Tanenbaum Research Institute, Mount Sinai Hospital
Co-authored papers 1
Dorota H Sendorek
Ontario Institute for Cancer Research
Co-authored papers 1
Hong Li
Qingdao Hospital of Traditional Chinese Medicine, Qingdao Haici Hospital
Co-authored papers 1
Paul C Boutros
University of California los angeles
Co-authored papers 1
Neil E Fleshner
University of Toronto
Co-authored papers 1
Theodorus H van der Kwast
University Health Network, University of Toronto
Co-authored papers 1
Sally Hanna
Mount Sinai Hospital
Co-authored papers 1
Craig Horbinski
Co-authored papers 1
Geoffrey A M Hunter
Ontario Institute for Cancer Research
Co-authored papers 1
Release 1.2